Related Experiment Video
Updated: Mar 25, 2026
08:26
Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
12.6K
Interferon Alpha-2a Therapy in Patients with Refractory Behçet Uveitis
Murat Hasanreisoglu1, Mehmet Ozgur Cubuk1, Sengul Ozdek1
1a Department of Ophthalmology , School of Medicine, Gazi University , Ankara , Turkey.
Ocular Immunology and Inflammation
|February 25, 2016
Summary
Interferon alfa-2a (IFNα2a) effectively treated Behçet uveitis in patients unresponsive to standard therapies. This treatment reduced uveitis attacks, offering a viable alternative when conventional methods fail.
Area of Science:
- Ophthalmology
- Immunology
- Rheumatology
Background:
- Behçet disease (BD) is a multisystem inflammatory disorder.
- Ocular involvement, specifically uveitis, significantly impacts patient morbidity.
- Conventional treatments like azathioprine-cyclosporine combination therapy may not be effective for all patients.
Purpose of the Study:
- To evaluate the efficacy of Interferon alfa-2a (IFNα2a) in patients with Behçet uveitis refractory to azathioprine-cyclosporine combination therapy.
Main Methods:
- A retrospective study included 39 patients with ocular Behçet disease.
- Group 1 (n=23) received azathioprine-cyclosporine combination therapy.
- Group 2 (n=16) received IFNα2a due to lack of response to conventional therapy.
Main Results:
- Patients receiving IFNα2a showed a significant reduction in the mean number of uveitis attacks per year (2.4 ± 1.8 vs 1.3 ± 2.0, p<0.05).
- No statistical difference in uveitis attacks or attack-free intervals was observed between the groups after IFNα2a administration.
- Both treatments demonstrated partial response.
Conclusions:
- IFNα2a serves as an effective alternative treatment for Behçet uveitis when standard combination therapies are insufficient.
- This finding supports the use of IFNα2a in managing refractory cases of Behçet uveitis.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
16
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
16
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:28Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
657
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
657
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
728
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
728
01:29Inflammatory Bowel Disease IV: Pharmacological Management
917
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
917